NIH Funds Psych Project to Push HPV Vaccine on South African Children

The HPV vaccine continues to cause harm in Africa, much of which is undocumented, and which will change with the AF VAERS.

In 2023, CHD Africa executive director Shabnam Palesa Mohamed interviewed on CHD.TV the heartbroken father of a severely HPV vaccine injured teenage child in South Africa. Despite international reports and court cases, the National Institutes of Health (NIH) awarded $340,000 to test psychological tactics aimed at persuading South African children and parents to accept the controversial HPV vaccine. This is according to documents obtained by Children’s Health Defense via a Freedom of Information Act request.

The Defender’s Brenda Baletti reports:

1. This is the first grant CHD identified that uses those same methods to target children in Africa. The research fits into a broader program across HHS institutions that includes hundreds of millions of dollars in grant funding to develop and test strategies to increase the uptake of all vaccines among vaccine-hesitant low-income communities and communities of color using “culturally tailored” messaging in the name of “health equity.”
2. The researchers hope the school-based communications strategies they develop will help increase child and adolescent HPV vaccination uptake in South Africa from the current rate of 37% of girls to the target rate of over 80% of all children ages 9-12. They hope to later use the same strategy in other low- and middle-income countries to increase their rates as well.
3. It is also in line with a push to provide substantial grant funding to increase HPV vaccination rates by “raising awareness” and combating “misinformation.” In addition to satisfying HHS’ goals, the South Africa project responds to a global program laid out in 2020 by the World Health Organization’s (WHO) World Health Assembly to eradicate cervical cancer as a public health problem worldwide, largely through HPV vaccination. Bill & Melinda Gates Foundation-backed Gavi, the Vaccine Alliance, last year announced it would invest more than $600 million to reach its goal of vaccinating 86 million girls against HPV in low- and middle-income countries by 2025, largely through national vaccination campaigns.
4. That announcement coincided with Gavi-supported national vaccination campaigns in Indonesia, Nigeria, ​​Bangladesh, Zambia, Sierra Leone and Eritrea over the past two years. South Africa was one of the earlier African countries to launch a national school-based vaccination campaign targeted at girls age 9 or older in fourth grade in public schools.
5. The researchers hypothesize declining HPV vaccination rates may be linked to COVID-19-related program interruptions, “increased medical mistrust, and vaccine hesitancy related to misinformation spread on social media,” which they seek to correct. They are expanding the HPV vaccine target population to include boys and children in private schools who were not initially included in South Africa’s national school-based vaccination program. Currently, GSK’s bivalent Cervarix vaccine is administered at no charge by school nurses in public schools on two designated days per year. Boys and private school children must pay for the shot. The HPV vaccine has not previously been made widely available to boys in the country, and most low- and middle-income national vaccination campaigns target girls only.
6. The Gardasil vaccine has been linked to myriad adverse events worldwide. Some of the signature impacts observed following HPV vaccination include permanently disabling autoimmune and neurological conditions, such as postural orthostatic tachycardia syndrome, or POTS, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome. Peer-reviewed scientific literature from the U.S., Australia, Denmark, Sweden, France and Japan, and statistics published by public health agencies in each of these countries, demonstrate plausible associations between HPV vaccination and autoimmune conditions.
7. According to an article in the British Journal of Clinical Pharmacology, most low- to middle-income countries have very low reporting rates for adverse events associated with vaccines or other pharmaceutical products, so it is difficult to track injuries related to previous vaccine rollouts
8. “The HPV vaccines have not been independently evaluated for both safety and efficacy,” said Dr. Shankara Chetty, a general practitioner and natural scientist from KwaZulu-Natal. “As such, no amount of coercive marketing strategies will suffice to honestly inform the recipients in their decision to consent. Seeing that minors are being targeted, it is imperative that the guardians of these minors are given all the current information and, more importantly, made aware of the lack of information on safety and efficacy to make an informed choice,” Chetty said. “This cannot be done by the industry profiting from its rollout.”
9. Shabnam Palesa Mohamed, executive director of CHD Africa, told The Defender she was disappointed to see South African researchers collaborating on the project. “It is difficult to understand why UKZN [University of KwaZulu-Natal] researchers don’t see this manipulative experiment on children as racist and dehumanizing. The pharmaceutical industry has a horrendous track record in Africa, where pharmacovigilance is weak or non-existent, largely due to pharma funding scientists, regulatory authorities and departments of health. UKZN is no exception. Its funders include the Bill and Melinda Gates Foundation.  I am reminded of behavioral scientists who helped the U.K. government manipulate the public [during the COVID-19 pandemic] and later said we have been systematically ‘stunned by the weaponization of behavioral psychology’ throughout the pandemic.”
10. Mohamed said, “Manipulating children and families from underprivileged backgrounds is the essence of medical colonialism. Not for the first time, there will be no proper informed consent with these children or their families, and there will be no compensation for harms or death caused. The role of the controversial NIH in behavioral manipulation — the same NIH that did not expose the WHO facilitating fertility experiments on Kenyan girls and women — smacks of pharmaceutical imperialism.”

Given  adverse effects and poor pharmacovigilance in Africa, reporting via and supporting AF VAERS is critical.

Read and share the full article about ongoing vaccine psychological warfare targeting Africa in The Defender here